Racial, ethnic, and socioeconomic survival disparities among children with high-risk neuroblastoma treated on upfront Children's Oncology Group clinical trials.

被引：0
|
作者：
Umaretiya, Puja J.
Naranjo, Arlene
Zhang, Fan
Park, Julie R.
Weiss, Brian D.
Granger, Meaghan
DuBois, Steven G.
Bagatell, Rochelle
Bona, Kira
机构：
[1] Dana Farber & Boston Childrens Canc & Blood Disor, Boston, MA USA
[2] Univ Florida, Childrens Oncol Grp, Stat & Data Ctr, Gainesville, FL USA
[3] Canc & Blood Disorders Ctr, Seattle, WA USA
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[5] Cook Childrens Med Ctr, Ft Worth, TX USA
[6] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[7] Childrens Hosp Philadelphia, Philadelphia, PA USA
[8] Childrens Hosp Boston, Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10005
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
    Matthay, Katherine K.
    Reynolds, C. Patrick
    Seeger, Robert C.
    Shimada, Hiroyuki
    Adkins, E. Stanton
    Haas-Kogan, Daphne
    Gerbing, Robert B.
    London, Wendy B.
    Villablanca, Judith G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1007 - 1013
  • [42] A safety and feasibility trial of 131I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study
    Weiss, Brian D.
    Yanik, Gregory
    Naranjo, Arlene
    Zhang, Fan F.
    Fitzgerald, Wendy
    Shulkin, Barry L.
    Parisi, Marguerite T.
    Russell, Heidi
    Grupp, Stephan
    Pater, Luke
    Mattei, Peter
    Mosse, Yael
    Lai, Hollie A.
    Jarzembowski, Jason A.
    Shimada, Hiroyuki
    Villablanca, Judith G.
    Giller, Roger
    Bagatell, Rochelle
    Park, Julie R.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (10)
  • [43] Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1
    Yanik, Gregory A.
    Parisi, Marguerite T.
    Naranjo, Arlene
    Nadel, Helen
    Gelfand, Michael J.
    Park, Julie R.
    Ladenstein, Ruth L.
    Poetschger, Ulrike
    Boubaker, Ariane
    Valteau-Couanet, Dominique
    Lambert, Bieke
    Castellani, Maria-Rita
    Bar-Sever, Zvi
    Oudoux, Aurore
    Kaminska, Anna
    Kreissman, Susan G.
    Shulkin, Barry L.
    Matthay, Katherine K.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 502 - 508
  • [44] Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Seibel, Nita L.
    Steinherz, Peter G.
    Sather, Harland N.
    Nachman, James B.
    DeLaat, Cynthia
    Ettinger, Lawrence J.
    Freyer, David R.
    Mattano, Leonard A., Jr.
    Hastings, Caroline A.
    Rubin, Charles M.
    Bertolone, Kathy
    Franklin, Janet L.
    Heerema, Nyla A.
    Mitchell, Torrey L.
    Pyesmany, Allan F.
    La, Mei K.
    Edens, Cheryl
    Gaynon, Paul S.
    BLOOD, 2008, 111 (05) : 2548 - 2555
  • [45] Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study
    Alexander, Sarah
    Kairalla, John A.
    Gupta, Sumit
    Hibbitts, Emily
    Weisman, Hannah
    Anghelescu, Doralina
    Winick, Naomi J.
    Krull, Kevin R.
    Salzer, Wanda L.
    Burke, Michael J.
    Gore, Lia
    Devidas, Meenakshi
    Embry, Leanne
    Raetz, Elizabeth A.
    Hunger, Stephen P.
    Loh, Mignon L.
    Hardy, Kristina K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (22)
  • [46] Upfront Window Vincristine/Irinotecan Treatment of High-Risk Hepatoblastoma: A Report From the Children's Oncology Group AHEP0731 Study Committee
    Katzenstein, Howard M.
    Furman, Wayne L.
    Malogolowkin, Marcio H.
    Krailo, Mark D.
    McCarville, M. Beth
    Towbin, Alexander J.
    Tiao, Greg M.
    Finegold, Milton J.
    Ranganathan, Sarangarajan
    Dunn, Stephen P.
    Langham, Max R.
    McGahren, Eugene D.
    Rodriguez-Galindo, Carlos
    Meyers, Rebecka L.
    CANCER, 2017, 123 (12) : 2360 - 2367
  • [47] Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report
    Ko, Richard H.
    Jones, Tamekia L.
    Radvinsky, David
    Robison, Nathan
    Gaynon, Paul S.
    Panosyan, Eduard H.
    Avramis, Ioannis A.
    Avramis, Vassilios I.
    Rubin, Joan
    Ettinger, Lawrence J.
    Seibel, Nita L.
    Dhall, Girish
    CANCER, 2015, 121 (23) : 4205 - 4211
  • [48] An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials
    Haduong, Josephine H.
    Heske, Christine M.
    Allen-Rhoades, Wendy
    Xue, Wei
    Teot, Lisa A.
    Rodeberg, David A.
    Donaldson, Sarah S.
    Weiss, Aaron
    Hawkins, Douglas S.
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2022, 69 (04)
  • [49] Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group
    Aye, Jamie M.
    Xue, Wei
    Palmer, Joshua D.
    Walterhouse, David O.
    Arnold, Michael A.
    Heaton, Todd E.
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
  • [50] Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study
    Abrahao, Renata
    Lichtensztajn, Daphne Y.
    Ribeiro, Raul C.
    Marina, Neyssa M.
    Keogh, Ruth H.
    Marcos-Gragera, Rafael
    Glaser, Sally L.
    Keegan, Theresa H. M.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (10) : 1819 - 1825
12345